Brutons Tyrosine Kinase
1 clinical trials · Condition
◉ Watch Brutons Tyrosine Kinase
| Record | Firm | Date |
|---|---|---|
| Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AML (NCT03642236) | Nanfang Hospital, Southern Medical University | 2018-08-01 |
Track Brutons Tyrosine Kinase automatically
Every clearance here is in the API, with alerts when new ones post.